Duloxetine-Induced Liver Injury: A Case Report

We present a case of a young (43-year-old), otherwise healthy, female patient who developed drug-induced liver injury (DILI) secondary to routine use of duloxetine. Our case aims to raise awareness amongst physicians about the possibility of duloxetine-induced liver injury. We recommend monitoring l...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Bilal, Abdelazeem, Basel, Revere, Taylor, Baral, Nischit, Kunadi, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019536/
https://www.ncbi.nlm.nih.gov/pubmed/33833926
http://dx.doi.org/10.7759/cureus.13715
_version_ 1783674391550230528
author Malik, Bilal
Abdelazeem, Basel
Revere, Taylor
Baral, Nischit
Kunadi, Arvind
author_facet Malik, Bilal
Abdelazeem, Basel
Revere, Taylor
Baral, Nischit
Kunadi, Arvind
author_sort Malik, Bilal
collection PubMed
description We present a case of a young (43-year-old), otherwise healthy, female patient who developed drug-induced liver injury (DILI) secondary to routine use of duloxetine. Our case aims to raise awareness amongst physicians about the possibility of duloxetine-induced liver injury. We recommend monitoring liver function tests (LFTs) when initiating or adjusting the dose of duloxetine, and intermittently thereafter, to facilitate early identification and management of potential DILI. 
format Online
Article
Text
id pubmed-8019536
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-80195362021-04-07 Duloxetine-Induced Liver Injury: A Case Report Malik, Bilal Abdelazeem, Basel Revere, Taylor Baral, Nischit Kunadi, Arvind Cureus Family/General Practice We present a case of a young (43-year-old), otherwise healthy, female patient who developed drug-induced liver injury (DILI) secondary to routine use of duloxetine. Our case aims to raise awareness amongst physicians about the possibility of duloxetine-induced liver injury. We recommend monitoring liver function tests (LFTs) when initiating or adjusting the dose of duloxetine, and intermittently thereafter, to facilitate early identification and management of potential DILI.  Cureus 2021-03-05 /pmc/articles/PMC8019536/ /pubmed/33833926 http://dx.doi.org/10.7759/cureus.13715 Text en Copyright © 2021, Malik et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Malik, Bilal
Abdelazeem, Basel
Revere, Taylor
Baral, Nischit
Kunadi, Arvind
Duloxetine-Induced Liver Injury: A Case Report
title Duloxetine-Induced Liver Injury: A Case Report
title_full Duloxetine-Induced Liver Injury: A Case Report
title_fullStr Duloxetine-Induced Liver Injury: A Case Report
title_full_unstemmed Duloxetine-Induced Liver Injury: A Case Report
title_short Duloxetine-Induced Liver Injury: A Case Report
title_sort duloxetine-induced liver injury: a case report
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019536/
https://www.ncbi.nlm.nih.gov/pubmed/33833926
http://dx.doi.org/10.7759/cureus.13715
work_keys_str_mv AT malikbilal duloxetineinducedliverinjuryacasereport
AT abdelazeembasel duloxetineinducedliverinjuryacasereport
AT reveretaylor duloxetineinducedliverinjuryacasereport
AT baralnischit duloxetineinducedliverinjuryacasereport
AT kunadiarvind duloxetineinducedliverinjuryacasereport

Ejemplares similares